Skip to main content

Glyphosate-based Weedkillers May Harm Key Species: Study

Glyphosate-based Weedkillers May Harm Key Species: Study

Glyphosate-based Weedkillers May Harm Key Species: Study

Introduction

Last month, a study was published in the medical journal Microbiome, in which researchers noted that chronic exposure to Roundup and other glyphosate-based weedkillers may cause embryonic development failure and alteration of key metabolic functions in the keystone species of the food chain.

The study was conducted by researchers from the U.K. who examined the effect of glyphosate on the water flea, Daphnia. Daphnia is a member of the order Cladocera and is considered a keystone species for the aquatic food web. As the flea is the building block of the food chain, any impact on it can affect the rest of the surrounding ecological webs.

Daphnia is the preferred food of small vertebrates and invertebrates as well as a grazer of algae and bacteria; hence, it occupies a central position in the food web of aquatic ecosystems. The researchers discovered that this could result in DNA damage and other problems in the species, affecting their ability to deliver critical ecosystem services.

In November, an associated study was published in the Journal of Hazardous Materials in which researchers from the University of Turku in Finland determined that half of the core human gut microbiome are “potentially sensitive” to glyphosate. The study illustrated that 54 percent of the species in the core human gut microbiome might be impacted by the main ingredient of the weedkiller Roundup.

Glyphosate is classified as a probable carcinogen, and its presence in the weedkiller Roundup has raised concerns of non-Hodgkin’s lymphoma (NHL) and other cancers among its users.

IARC, considered to be the apex in the field of cancer research, classified glyphosate as a “probable human carcinogen.” According to IARC, Roundup is made up of other ingredients that are toxic in themselves, and are also known to increase the toxicity of glyphosate. Monsanto has known this for many years but still refuses to study the link between cancer and Roundup.

Monsanto has a brief history of legal troubles and Glyphosate is just another herbicide of the company to attract lawsuits. Plaintiffs across the U.S. have filed numerous lawsuits. 

In the legal world, attorneys representing Roundup manufacturer filed a joint case management statement and litigation plan in November with U.S. District Judge Vince Chhabria, overseeing the rising weedkiller litigation, indicating that the company missed the deadline set by the court. The deadline was set to the same day on which the statement was filed, and the judge had indicated to restart the litigation at full throttle over claims alleging the weedkiller of causing non-Hodgkin's lymphoma.

Bayer, the manufacturer of the controversial weedkiller, Roundup, is facing approximately 125,000 filed and unfiled claims. The lawsuits are presided by U.S. District Judge Vince Chhabria under MDL No. 2741 in the U.S. District Court for the Northern District of California.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Study Links Roundup Chemical to Long-Term Brain Damage

Categories: Roundup

A recent study suggests that exposure to the widely used herbicide Roundup, which contains the active ingredient glyphosate, may be…

Zimmer Biomet Gets FDA Approval for Cementless Partial Knee

Zimmer Biomet announced it has received supplemental FDA premarket approval (PMA) for the Oxford Cementless Partial…

Court Names Special Masters for Bard Mesh Claim Settlements

Categories: Hernia Mesh

The U.S. District Judge overseeing the federal litigation involving Bard hernia mesh lawsuits has appointed two…

Demand Letter or Medical Record Review?     
Free Trials + 10% Discount!